Citizens JMP Reiterates Market Outperform Rating on Prime Medicine (PRME)
Tweet Send to a Friend
Citizens JMP analyst Silvan Tuerkcan reiterated a Market Outperform rating and $10.00 price target on Prime Medicine (NASDAQ: PRME).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
